prv-3279
mAbexperimentalMulti-specific
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 30, 2019 (NCT03955666)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
- Multi-specific
- Yes
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05087628 | Phase 2 | Oct 31, 2021 | Provention Bio, Inc. |
| NCT03955666 | Phase 1 | Jun 30, 2019 | Provention Bio, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Provention Bio, Inc. | For profit | 2 | 2 | 2 | 2019 |
1 organizations
Page 1 / 1